版本:
中国

BRIEF-Lipocine completes enrollment in the LPCN 1021 fixed dose clinical trials

April 24 Lipocine Inc

* Lipocine completes enrollment in the LPCN 1021 fixed dose clinical trials

* To announce top-line results from LPCN 1021 fixed dose clinical trials in June 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐